MILIND JAVLE to Hyperphosphatemia
This is a "connection" page, showing publications MILIND JAVLE has written about Hyperphosphatemia.
Connection Strength
0.202
-
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study. Lancet Gastroenterol Hepatol. 2021 10; 6(10):803-815.
Score: 0.202